Acryl-3,5-bis(2,4-difluorobenzylidene)-4-piperidone targeting cellular JUN proto-oncogene, AP-1 transcription factor subunit inhibits head and neck squamous cell carcinoma progression
Authors:
- Levi ArnoldLALevi Arnold
- Juan Pineda GomezJGJuan Pineda Gomez
- Michael BarryMBMichael Barry
- Marrion YapMYMarrion Yap
- Laura JacksonLJLaura Jackson
- Thuc LyTLThuc Ly
- David StandingDSDavid Standing
- Subhash B. PadhyeSPSubhash B. Padhye
- Bernhard BiersackBernhard Biersack
- Shrikant AnantSAShrikant Anant
- Sufi Mary ThomasSTSufi Mary Thomas
Open Access
- 31 October 2023
- journal article
- research article
- Published by Open Exploration Publishing in Exploration of Targeted Anti-tumor Therapy
- Vol. 4 (5) , 1104-1121
Abstract
Aim: Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide with a survival rate below fifty percent. Addressing meager therapeutic options, a series of small mKeywords
This publication has 58 references indexed in Scilit:
- Barriers to transmission of transcriptional noise in a c‐fos c‐jun pathwayMolecular Systems Biology, 2013
- Cisplatin-Based Chemotherapy Options for Recurrent and/or Metastatic Squamous Cell Cancer of the Head and NeckClinical Medicine Insights: Therapeutics, 2013
- Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activationProceedings of the National Academy of Sciences, 2012
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- 3,5-Bis(2,4-Difluorobenzylidene)-4-piperidone, a Novel Compound That Affects Pancreatic Cancer Growth and AngiogenesisMolecular Cancer Therapeutics, 2011
- Platinum-Based Chemotherapy plus Cetuximab in Head and Neck CancerNew England Journal of Medicine, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Expression of Jun family members in human colorectal adenocarcinomaCarcinogenesis, 2000
- Altered cJun expression: An early event in human lung carcinogenesis: Szabo E, Riffe ME, Steinberg SM, Birrer MJ, Linnoila RI. Cancer Prevention/Control Division, Biomarkers/Prevention Res. Branch, National Cancer Institute, 9610 Medical Center Drive, Rockville, MD 20850. Cancer Res 1996;56:305-15Lung Cancer, 1996
- Transcription factors junB and c-jun are selectively up-regulated and functionally implicated in fibrosarcoma development.Genes & Development, 1992